We felt from this that there was, there was reasonable evidence to introduce this programme into our practice, and we, we looked at our patients erm at  and  , and we looked at all patients who'd had moderately or well-differentiated transition cell carcinoma of the bladder at diagnosis, a non-invasive tumour, small, solitary, with a minimum follow up of one year.